M&G Investment Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$9.75M Sell
120,407
-6,636
-5% -$516K 0.03% 210
2023
Q3
$9.53M Buy
127,043
+4,965
+4% +$382K 0.04% 202
2023
Q2
$9.4M Buy
122,078
+88,397
+262% +$7.05M 0.04% 207
2023
Q1
$2.8M Sell
33,681
-38,780
-54% -$3.21M 0.01% 277
2022
Q4
$6.23M Buy
72,461
+1,638
+2% +$130K 0.03% 207
2022
Q3
$4.39K Sell
70,823
-285
-0.4% -$18K 0.03% 232
2022
Q2
$4.41K Buy
71,108
+111
+0.2% +$6.87K 0.03% 254
2022
Q1
$4.19K Buy
70,997
+3,887
+6% +$248K 0.01% 264
2021
Q4
$4.9K Sell
67,110
-219,826
-77% -$15.1M 0.01% 253
2021
Q3
$20.1K Buy
286,936
+1,096
+0.4% +$77K 0.05% 201
2021
Q2
$19.7K Buy
285,840
+184,538
+182% +$12.3M 0.05% 192
2021
Q1
$6.58K Sell
101,302
-18,545
-15% -$1.2M 0.02% 213
2020
Q4
$6.95K Sell
119,847
-13,969
-10% -$843K 0.04% 211
2020
Q3
$8.43M Sell
133,816
-5,073
-4% -$352K 0.08% 179
2020
Q2
$10.7M Buy
138,889
+90,322
+186% +$6.92M 0.11% 152
2020
Q1
$3.64M Sell
48,567
-13,976
-22% -$966K 0.04% 224
2019
Q4
$4.07M Buy
+62,543
New +$4.07M 0.04% 239

Other funds holding GILD

M&G Investment Management's GILD Position: Q4 2023 in Review

M&G Investment Management reduced its Gilead Sciences (GILD) stake by 5.2% in Q4 2023, selling an estimated $516K and leaving 120,407 shares worth $9.75M. The position accounts for 0.03% of the portfolio, ranked #210.

M&G Investment Management first reported a position in GILD in Q4 2019 and has held it in 17 quarters since. The position peaked at $10.7M in Q2 2020. 1,776 funds tracked by Wall St. Rank hold GILD as of Q4 2023.

  • M&G Investment Management held 120,407 shares of Gilead Sciences worth $9.75M as of Q4 2023.
  • M&G Investment Management sold 6,636 Gilead Sciences shares in Q4 2023, an estimated $516K.
  • Gilead Sciences made up 0.03% of M&G Investment Management's portfolio in Q4 2023, its #210 holding.
  • M&G Investment Management first reported a position in Gilead Sciences in Q4 2019 and has held it in 17 quarters since.
  • M&G Investment Management's Gilead Sciences position peaked at $10.7M in Q2 2020.
  • 1,776 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2023.

Based on M&G Investment Management's 13F filing for Q4 2023, filed 8 Feb 2024.